|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||14.15 - 14.84|
|52 Week Range||12.72 - 40.22|
|Beta (5Y Monthly)||1.36|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 10, 2022 - Aug 15, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||45.80|
Subscribe to Yahoo Finance Plus to view Fair Value for TCNNF
Trulieve Cannabis CEO Kim Rivers acquired 14,000 shares of the cannabis company on Tuesday at a price of $14.45 a share for a total purchase value of about $202,300, according to a filing. Rivers now owns just under 2.5 million shares. Trulieve CFO Alex D'Amico acquired 1,500 shares and Trulieve president Steve White bought 7,000 shares. All told, Trulieve management bought 31,650 shares in recent days. Trulieve shares are down 2.9% in premarket trades. The stock has lost 45.7% of its value in 2
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the grand opening of its third and fourth medical dispensaries in West Virginia. Located at 4701 MacCorkle Ave. SW in South Charleston and 152 Park Shopping Center in Parkersburg, both dispensaries will open at 10 a.m. on Saturday, May 21, 2022.
Despite momentum towards marijuana legalization, the country's biggest cannabis companies are failing to turn a profit.